CCL5 and depressive symptom measurement: RANTES activation has been previously implicated in pathological processes for several inflammatory and behavioral disorders including atherosclerosis, autoimmune disorders (e.g., asthma, lupus erythematosus), depression, traumatic brain injury, schizophrenia and obesity [26,38].